CAMP
Camp4 enters securities pact with Decibel II Acquisition
Camp4 Therapeutics Corp entered into a securities purchase agreement with Decibel II Acquisition Corp, regarding a potential business combination.
Latest 3 stories ยท newest Sep 28, 2026
Camp4 Therapeutics Corp entered into a securities purchase agreement with Decibel II Acquisition Corp, regarding a potential business combination.
Camp4 Therapeutics received Australian regulatory approval to begin a Phase 1/2 clinical trial of CMP-002 for SYNGAP1 disorder. This milestone enables a second private offering that could raise up to $50 million.
The same CAMP feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/CAMP/newsSTART FREE